T9593 |
Senaparib
|
1401682-78-7
|
99.41%
|
|
Senaparib (IMP4297) is a novel highly potent and selective oral PARP1/2 inhibitor with strong antitumor activity.
|
T12064 |
Niraparib (R-enantiomer)
|
1038915-58-0
|
99.41%
|
|
Niraparib R-enantiomer (MK 4827 R-enantiomer) is an inhibitor of PARP1(IC50 of 2.4 nM).
|
T8806 |
Fluzoparib
|
1358715-18-0
|
99.38%
|
|
Fluzoparib (SHR3162) is a novel, potent, and orally available inhibitor of PARP, potentially for the treatment of solid tumours.
|
T12695 |
RBN-2397
|
2381037-82-5
|
99.36%
|
|
RBN-2397 is a potent, selective and orally active accross species NAD+ competitive PARP7 inhibitor with IC50 less than 3 nM.
|
T1807 |
JW 55
|
664993-53-7
|
99.36%
|
|
JW 55 (JW55) is an effective and selective β-catenin signaling pathway inhibitor, works by inhibition of the PARP domain of tankyrase 1 and tankyrase 2 (TNKS1/2)...
|
T9024 |
OUL35
|
6336-34-1
|
99.3%
|
|
OUL35 (NSC-39047) is a selective PARP-10 inhibitor, and small-molecule ARTD10 inhibitor. OUL35 has been shown to rescue cells from ARTD10-induced cell death.
|
T22264 |
AZ9482
|
1825345-33-2
|
99.29%
|
|
AZ9482 is a selective and potent inhibitor of PARP featuring an amide linkage to a 2-piperazinyl-3-cyano-pyridine. AZ9482 exhibits very potent activity of centro...
|
T6366 |
A-966492
|
934162-61-5
|
99.25%
|
|
A-96649 is a new-type and effective inhibitor. The Ki of A-966492 for PARP1 and PARP2 is 1 nM and 1.5 nM, respectively.
|
TN1891 |
Lupiwighteone
|
104691-86-3
|
99.20%
|
|
Lupiwighteone has anti-angiogenesis potential, it also has anticancer and cancer preventive effects on SH-SY5Y cells.
|
T72553 |
ARTD10/PARP10-IN-1
|
1708103-76-7
|
99.14%
|
|
ARTD10/PARP10-IN-1 is a potent PARP inhibitor of the mono-ADP ribosyltransferases ARTD7/PARP15, ARTD8/PARP14, ARTD10/PARP10 and poly ADP-ribose polymerase-1 (ART...
|
T6127 |
Rucaparib Phosphate
|
459868-92-9
|
99.1%
|
|
Rucaparib Phosphate (PF-01367338 phosphate) is an inhibitor of PARP (Ki: 1.4 nM for PARP1) that is used in clinical therapy to sensitize cancer cells to chemothe...
|
T4241 |
Rubiadin
|
117-02-2
|
99.1%
|
|
Rubiadin (1,3-Dihydroxy-2-Methylanthracene-9,10-Dione) possesses potent antioxidant property, it can prevent lipid peroxidation induced by FeSO4 and t-butylhydro...
|
T9497 |
Niraparib tosylate monohyrate
|
1613220-15-7
|
99.09%
|
|
Niraparib, also know as MK-4827, is an inhibitor of poly (ADP-ribose) polymerase (PARP) with potential antineoplastic activity. MK4827 inhibits PARP activity, en...
|
T73027 |
PARP-2-IN-3
|
2915650-86-9
|
99.08%
|
|
PARP-2-IN-3 is used as a potent PARP-2 inhibitor (IC50=0.07 μM) with anti-tumor activity that induces apoptosis and necrosis in cancer cells, and can be used for...
|
T1878 |
XAV-939
|
284028-89-3
|
99.04%
|
|
XAV-939 (NVP-XAV939) is a Tankyrase (TNKS) inhibitor that inhibits TNKS1 and TNKS2 (IC50=11/4 nM). XAV-939 selectively inhibits Wnt/β-catenin-mediated transcript...
|
T73496 |
OUL232
|
943119-42-4
|
99.04%
|
|
OUL232 is a potent single ARTs PARP7, PARP10, PARP11, PARP12, PARP14 and PARP15 inhibitor for cancer and tumour research.
|
T7443 |
4'-Methoxychalcone
|
959-23-9
|
98.93%
|
|
4'-Methoxychalcone with a variety of pharmacological activities, such as anti-tumor and anti-inflammatory activities.
|
TN1416 |
Ayanin
|
572-32-7
|
98.9%
|
|
Ayanin has vasorelaxant activity, it also may have the potential for use in treating allergic asthma.The IC(50) value of Ayanin (quercetin-3,7,4'-O-trimethylethe...
|
T2124 |
PJ34 hydrochloride
|
344458-15-7
|
98.87%
|
|
PJ34 hydrochloride (PJ34 HCl) is a potent specific inhibitor of PARPl/2.
|
T6181 |
UPF 1069
|
1048371-03-4
|
98.84%
|
|
UPF 1069 is a specific PARP2 inhibitor ( IC50: 0.3 μM). It is ~27-fold selective against PARP1.
|